Fintelmann V - Search Results

1

Antimitochondrial antibody profiles in primary biliary cirrhosis distinguish at early stages between a benign and a progressive course: a prospective study on 200 patients followed for 10 years.

Klein R, Pointner H, Zilly W, Glässner-Bittner B, Breuer N, Garbe W, Fintelmann V, Kalk JF, Müting D, Fischer R, Tittor W, Pausch J, Maier KP, Berg PA. Klein R, et al. Among authors: fintelmann v. Liver. 1997 Jun;17(3):119-28. doi: 10.1111/j.1600-0676.1997.tb00793.x. Liver. 1997. PMID: 9249725 Clinical Trial.

2

Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease. A retrospective analysis of 76 patients over 6-18 years.

Klein R, Klöppel G, Garbe W, Fintelmann V, Berg PA. Klein R, et al. Among authors: fintelmann v. J Hepatol. 1991 Jan;12(1):21-7. doi: 10.1016/0168-8278(91)90903-o. J Hepatol. 1991. PMID: 2007772

3

The antimitochondrial antibody anti-M9. A marker for the diagnosis of early primary biliary cirrhosis.

Klein R, Klöppel G, Fischer R, Fintelmann V, Müting D, Berg PA. Klein R, et al. Among authors: fintelmann v. J Hepatol. 1988 Jun;6(3):299-306. doi: 10.1016/s0168-8278(88)80046-1. J Hepatol. 1988. PMID: 3392380

4

Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.

Weber P, Brenner J, Stechemesser E, Klein R, Weckenmann U, Klöppel G, Kirchhof M, Fintelmann V, Berg PA. Weber P, et al. Among authors: fintelmann v. Hepatology. 1986 Jul-Aug;6(4):553-9. doi: 10.1002/hep.1840060402. Hepatology. 1986. PMID: 3089894

5

[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)].

Hampel KE, Billich C, Dannenmeier HD, Fintelmann V, Fischer R, Schmid E, Treske U, Walz A. Hampel KE, et al. Among authors: fintelmann v. Munch Med Wochenschr. 1972 May 12;114(19):925-9. Munch Med Wochenschr. 1972. PMID: 4559199 Clinical Trial. German. No abstract available.

6

Modern phytotherapy and its uses in gastrointestinal conditions.

Fintelmann V. Fintelmann V. Planta Med. 1991 Oct;57(7):S48-52. Planta Med. 1991. PMID: 1956958 Review.

7

Modern phytotherapy and its uses in gastrointestinal conditions.

Fintelmann V. Fintelmann V. Planta Med. 1991 Oct;57(7 Suppl):S48-52. doi: 10.1055/s-2006-960229. Planta Med. 1991. PMID: 17226223

8

[Pharmacological properties and therapeutic profile of artichoke (Cynara scolymus L.)].

Wegener T, Fintelmann V. Wegener T, et al. Among authors: fintelmann v. Wien Med Wochenschr. 1999;149(8-10):241-7. Wien Med Wochenschr. 1999. PMID: 10483691 Review. German.

9

Efficacy and safety of a combination herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix for the prophylactic treatment of patients with respiratory tract diseases: a randomised, prospective, double-blind, placebo-controlled phase III trial.

Fintelmann V, Albrecht U, Schmitz G, Schnitker J. Fintelmann V, et al. Curr Med Res Opin. 2012 Nov;28(11):1799-807. doi: 10.1185/03007995.2012.742048. Epub 2012 Oct 31. Curr Med Res Opin. 2012. PMID: 23083066 Clinical Trial.

10

Efficacy and tolerability of a Rhodiola rosea extract in adults with physical and cognitive deficiencies.

Fintelmann V, Gruenwald J. Fintelmann V, et al. Adv Ther. 2007 Jul-Aug;24(4):929-39. doi: 10.1007/BF02849986. Adv Ther. 2007. PMID: 17901042 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page